Trial Profile
Randomized contorol trial to determine the Efficacy and Safety on suppression of recurrence after surgery with Dinagest or GnRH for endometriosis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2015
Price :
$35
*
At a glance
- Drugs Dienogest (Primary) ; Gonadotropin releasing hormone
- Indications Endometriosis
- Focus Therapeutic Use
- 06 Jun 2015 Planned End Date changed from 1 Jan 2012 to 31 Dec 2015 as reported by University Hospital Medical Information Network - Japan.
- 06 Jun 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 16 Jan 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.